TYRA BIOSCIENCES, INC. TYRA
$20.12 +$0.39 (+1.98%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $20.29 +0.84%
Open$19.62
Prev close$19.73
Day range$19.48 – $20.44
Volume467.6K
Market cap$1.39B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$54.89M-66.6% YoY
Net profit-$51.12M-71.2% YoY
Diluted EPS-$0.74-48.0% YoY
Free cash flow-$32.30M-44.1% YoY
Operating cash flow-$32.21M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-34.9%
Return on assets-33.0%
Return on invested capital-37.0%
Current ratio23.93
Liabilities / assets4.8%
Cash & investments$700.55M
Total debt$4.94M
Net cash (debt)$695.61M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $54.89M | $49.00M | $42.00M | $132.76M | $36.52M |
| Selling and Admin Expenses | $11.74M | $9.81M | $8.53M | $29.83M | $8.33M |
| -General & Admin Expense | $11.74M | $9.81M | $8.53M | $29.83M | $8.33M |
| Research & Development | $43.14M | $39.20M | $33.47M | $102.93M | $28.19M |
| Operating Profit | -$54.89M | -$49.00M | -$42.00M | -$132.76M | -$36.52M |
| Net Non-Operating Interest Income (Expense) | $3.76M | $3.45M | $2.69M | $12.82M | $2.68M |
| Non-Operating Interest Income | $3.76M | $3.45M | $2.69M | $12.82M | $2.68M |
| Pretax Profit | -$51.12M | -$45.56M | -$39.31M | -$119.95M | -$33.83M |
| Net Profit | -$51.12M | -$45.56M | -$39.31M | -$119.95M | -$33.83M |
| Profit from Continuing Operations | -$51.12M | -$45.56M | -$39.31M | -$119.95M | -$33.83M |
| Net Income to Parent Company | -$51.12M | -$45.56M | -$39.31M | -$119.95M | -$33.83M |
| Net Income to Common Stockholders | -$51.12M | -$45.56M | -$39.31M | -$119.95M | -$33.83M |
| Basic EPS | -$0.74 | -$0.69 | -$0.64 | -$2.01 | -$0.57 |
| Diluted EPS | -$0.74 | -$0.69 | -$0.64 | -$2.01 | -$0.57 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $727.53M | $383.36M | $412.04M | $282.61M | $282.61M |
| Total Current Assets | $711.62M | $366.97M | $394.61M | $265.45M | $265.45M |
| Cash and Cash Equivalents & Short-Term Investments | $700.55M | $353.94M | $383.47M | $256.00M | $256.00M |
| -Cash and Cash Equivalents | $456.02M | $73.84M | $84.96M | $77.39M | $77.39M |
| -Short Term Investments | $244.53M | $280.11M | $298.51M | $178.62M | $178.62M |
| Other Current Assets | $11.07M | $13.02M | $11.15M | $9.45M | $9.45M |
| Total Non-Current Assets | $15.91M | $16.40M | $17.43M | $17.16M | $17.16M |
| Net PPE | $6.26M | $6.48M | $6.66M | $6.89M | $6.89M |
| -Gross PPE | $6.26M | $6.48M | $6.66M | $6.89M | $6.89M |
| Other Non-Current Assets | $9.65M | $9.91M | $10.77M | $10.27M | $10.27M |
| Total Liabilities | $34.68M | $29.70M | $24.47M | $23.43M | $23.43M |
| Total Current Liabilities | $29.74M | $24.62M | $19.26M | $18.09M | $18.09M |
| Payables | $3.30M | $2.33M | $3.64M | $1.18M | $1.18M |
| -Accounts Payable | $3.30M | $2.33M | $3.64M | $1.18M | $1.18M |
| Current Accrued Expenses | $25.92M | $21.78M | $15.13M | $16.44M | $16.44M |
| Short-Term Debt and Capital Lease Obligation | $521,000.00 | $504,000.00 | $488,000.00 | $472,000.00 | $472,000.00 |
| -Current Capital Lease Obligation | $521,000.00 | $504,000.00 | $488,000.00 | $472,000.00 | $472,000.00 |
| Total Non-Current Liabilities | $4.94M | $5.08M | $5.21M | $5.34M | $5.34M |
| Long Term Debt and Capital Lease Obligation | $4.94M | $5.08M | $5.21M | $5.34M | $5.34M |
| -Long Term Capital Lease Obligation | $4.94M | $5.08M | $5.21M | $5.34M | $5.34M |
| Total Equity | $692.84M | $353.66M | $387.58M | $259.18M | $259.18M |
| Stockholders' Equity | $692.84M | $353.66M | $387.58M | $259.18M | $259.18M |
| Capital Stock | $7,000.00 | $6,000.00 | $6,000.00 | $5,000.00 | $5,000.00 |
| -Common Stock | $7,000.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Preferred Stock | $0.00 | $6,000.00 | $6,000.00 | $5,000.00 | $5,000.00 |
| Additional Paid-In Capital | $1.20B | $810.36M | $798.03M | $630.04M | $630.04M |
| Retained Earnings | -$507.24M | -$456.12M | -$410.56M | -$371.26M | -$371.26M |
| Gains/Losses Not Affecting Retained Earnings | -$1.28M | -$580,000.00 | $107,000.00 | $393,000.00 | $393,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$32.21M | -$31.08M | -$32.57M | -$95.14M | -$23.62M |
| Net cash flow from continuing operations | -$32.21M | -$31.08M | -$32.57M | -$95.14M | -$23.62M |
| Net Income from Continuing Operations | -$51.12M | -$45.56M | -$39.31M | -$119.95M | -$33.83M |
| Depreciation & Depletion & Amortization | $130,000.00 | $138,000.00 | $138,000.00 | $546,000.00 | $132,000.00 |
| Change in Working Capital | $6.76M | $4.32M | -$1.23M | -$1.63M | $2.58M |
| -Change in Prepaid Assets | $2.22M | -$1.02M | -$2.44M | -$5.08M | $404,000.00 |
| -Change in Payables and Accrued Expense | $4.53M | $5.32M | $1.20M | $3.37M | $2.16M |
| -Change In Other Working Capital | $14,000.00 | $17,000.00 | $17,000.00 | $83,000.00 | $17,000.00 |
| Net cash flow from investing | $34.92M | $17.85M | -$120.24M | $72.46M | $34.38M |
| Net Cash Flow from Continuing Investing Activities | $34.92M | $17.85M | -$120.24M | $72.46M | $34.38M |
| Net PPE Purchase and Sale | -$90,000.00 | -$66,000.00 | -$88,000.00 | -$141,000.00 | -$57,000.00 |
| Net Investment Purchase and Sale | $35.01M | $17.92M | -$120.16M | $72.60M | $34.43M |
| Financing Cash Flow | $379.47M | $2.10M | $160.38M | $8.10M | $4.68M |
| Net Cash Flow from Continuing Financing Activities | $379.47M | $2.10M | $160.38M | $8.10M | $4.68M |
| Net Common Stock Issuance | $376.80M | $0.00 | $147.85M | $0.00 | $0.00 |
| Proceeds from Stock Option Exercised | $2.68M | $2.10M | $12.53M | $8.10M | $4.68M |
| Ending Cash Balance | $457.02M | $74.84M | $85.96M | $78.39M | $78.39M |
| Net Change in Cash | $382.18M | -$11.12M | $7.57M | -$14.58M | $15.44M |
| Beginning Cash Balance | $74.84M | $85.96M | $78.39M | $92.97M | $62.95M |
| Free Cash Flow | -$32.30M | -$31.14M | -$32.66M | -$95.28M | -$23.68M |
No comments yet — be the first to weigh in on TYRA.
Sign in to join the discussion.